PATIENTS (ARCC) TREATED WITH MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR (MTORI) THERAPY FOLLOWING FIRST-LINE PAZOPANIB (PAZ) IN A US COMMUNITY ONCOLOGY SETTING

mag(2014)

引用 23|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要